Medical Equipment

GORE COMPLETES FIRST IN-HUMAN IMPLANTS OF THE GORE® VIAFORT VASCULAR STENT

CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease. FLAGSTAFF, Ariz., Oct. 29, 2022 /PRNewswire/ -- W. L. Gore & Associat...

2022-10-29 02:10 9629

hemotune Applauded by Frost & Sullivan for Enabling Selective and Efficient Extraction of Large Compounds from Blood With Its Blood Purification Platform

HemoSystem improves patient outcomes while shortening the length of stay in intensive care units, reducing the sepsis burden for patients, hospitals, and healthcare systems. SAN ANTONIO, Oct. 27, 2022 /PRNewswire/ -- Recently, Frost & Sullivan assessed the blood purification technology industry a...

2022-10-27 23:00 2925

Medtecs to showcase its world-leading PPE solutions in Germany and France

TAIPEI, Oct. 27, 2022 /PRNewswire/ -- As countries reopen their borders for international travel with global vaccination coverage on the rise, the world is slowly returning to pre-pandemic activity levels since the COVID-19 outbreak nearly 3 years ago. Needless to say, personal protective equi...

2022-10-27 18:14 1301

DR. FAIKA KHAN CEO OF CITY DOCTOR PVT. LTD. AND MR ALI J HASHMAT CEO OF CURE PARTNERS PVT. LTD. ANNOUNCEMENT OF FULL ACQUISITION OF "THE MEDICAL LABORATORY PVT. LTD." DBA ZEENAT LABORATORIES

NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Dr Faika Khan CEO of CITY DOCTOR PVT. LTD. andMr. Ali J Hashmat of CURE PARTNERS PVT. LTD. announced 100% acquisition of"The Medical laboratory Pvt. Ltd." Doing Businesses as (DBA) "ZEENAT LAB", one of the most renowned lab with a history of over 50 plus ye...

2022-10-27 10:19 2651

Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK

Sweden-Gothenburg and Germany-Pforzheim, October 25, 2022 ( https://news.cision.com/mentice-ab).  GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzh...

2022-10-25 23:23 2467

MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program

MiRXES Translator Program will accelerate revenue growth of start-ups and importantly, adoption of preventive healthcare solutions globally SINGAPORE, Oct. 25, 2022 /PRNewswire/ -- MiRXES , a Singapore-headquartered biotechnology company focused on saving lives and improving...

2022-10-25 11:50 4443

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last  week "MedAlliance to be acquired by Cordis",MedAlliance is pleased to make the following announcement:  SELUTION SLR™, MedAlliance's novel sirolimus...

2022-10-25 08:00 3651

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutatio...

2022-10-24 20:14 3915

Transcenta To Present First-In-Class TST003 Antibody Program at the 10th TEMTIA Meeting

SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta is i...

2022-10-24 16:08 3253

United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World's First Total-Body PET/CT

* To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congre...

2022-10-24 16:00 2454

Advanced Instruments Introduces the OsmoPRO® MAX Automated Osmometer to Maximize Clinical Lab Productivity

Our newest osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance. NORWOOD, Mass., Oct. 22, 2022 /PRNewswire/ -- Recently, Advanced Instruments announce...

2022-10-22 03:01 8486

SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease

TAMPA, Fla., Oct. 21, 2022 /PRNewswire/ -- Concept Medical Inc.  announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA

2022-10-21 20:36 4367

EDAN Forays into Molecular Point-of-Care Market with Its First-Ever Molecular Diagnostics Solution Released at Medlab Asia 2022

Developed based on Loop-Mediated Isothermal Amplification (LAMP), the new molecular diagnostics analysis system, ClariLight CL30, gives on-the-spot results and empowers physicians for early infectious disease diagnostics because of its agility, fast and flexibility. BANGKOK, Thailand, Oct. 19, 2...

2022-10-19 19:59 3063

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST

GOTHENBURG, Sweden, Oct. 19, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presen...

2022-10-19 15:30 2036

MedAlliance to be Acquired by Cordis

GENEVA, Oct. 19, 2022 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of$35M and upfront closing payment of$200M, regulatory achievement milestones of up to $125M ...

2022-10-19 08:00 3017

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology

* Brings Eyenuk's total funding to over $43 million * Funding round led by AXA IM Alts; joined by T&W Medica A/S, Kendall Capital Partners, and others * Eyenuk adds three new board members * Funding affirms Eyenuk's standing as the global leader among developers of autonomous AI solutions ...

2022-10-17 19:30 2075

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

* New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare's immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials * Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve ther...

2022-10-17 13:00 2849

3M V.A.C. Therapy negative pressure wound therapy achieves key medical evidence milestone, surpassing 2,000 peer-reviewed medical journal studies published

ST. PAUL, Minn., Oct. 13, 2022 /PRNewswire/ -- 3M Health Care's Medical Solutions Division today announced its3M™ V.A.C.® Therapy negative pressure wound therapy (NPWT) has surpassed a clinical evidence milestone of 2,000 published, peer-reviewed medical journal studies. V.A.C. Therapy is the fir...

2022-10-13 21:10 2342

Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. HUNTINGDON VALLEY, Pa., Oct. 13...

2022-10-13 20:00 1798

Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety

* The Digital Therapeutic (DTx) was developed by DTx leader Alex Therapeutics using the proprietary "Alex DTx Platform"[1] in partnership with Vicore Pharma * In the study patients with Idiopathic Pulmonary Fibrosis (IPF) and anxiety were given the DTx * Safety, functionality, and user exper...

2022-10-13 14:39 1783
1 ... 61626364656667 ... 94